Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma
Authors:
- 14 October 2014
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 46 (1) , 45-56
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Ubiquitin-proteasome system has been shown to play a pivotal role in the pathophysiology of HCC and other malignancies. UBE2Q1 is a putative E2 ubiquitin conjugating enzyme, and may be involved in the regulation of cancer-related proteins. In this study, we investigated the expression pattern of UBE2Q1 in HCC cell lines and human HCC specimens, and its potential clinical and biological significance in HCC. Western blot and immunohistochemical analyses revealed that UBE2Q1 was significantly upregulated in HCC tumorous tissues compared with the adjacent noncancerous ones. Next, univariate and multivariate survival analyses were performed to determine the prognostic significance of UBE2Q1 in HCC. The results showed that upregulated expression of UBE2Q1 was positively correlated with high histological grades of HCC and predicted poor prognosis. In addition, the expression of UBE2Q1 was progressively increased in serum-refed HCC cells. UBE2Q1 depletion by small interfering RNA inhibited cell proliferation and led to G1 phase arrest in HepG2 and BEL-7404 cells. Furthermore, we showed that cells transfected with UBE2Q1-targeting siRNA resulted in significant increase in the levels of p53, p21 in HepG2 and BEL-7404 cells. These data imply that UBE2Q1 is upregulated in liver cancer cell lines and tumorous samples and may play a role in the development of HCC.Keywords
This publication has 46 references indexed in Scilit:
- High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinomaMedical Oncology, 2013
- Increased α-Tubulin1b Expression Indicates Poor Prognosis and Resistance to Chemotherapy in Hepatocellular CarcinomaDigestive Diseases and Sciences, 2013
- Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivoTumor Biology, 2012
- The Ubiquitin Ligase TRAF6 Negatively Regulates the JAK-STAT Signaling Pathway by Binding to STAT3 and Mediating Its UbiquitinationPLOS ONE, 2012
- APC/C-mediated multiple monoubiquitylation provides an alternative degradation signal for cyclin B1Nature Cell Biology, 2012
- Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathwayJournal of Lipid Research, 2011
- A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine PhosphorylationJournal of Biological Chemistry, 2011
- Overexpression of the novel human gene, UBE2Q2, in breast cancerCancer Genetics and Cytogenetics, 2010
- CHIP Deficiency Decreases Longevity, with Accelerated Aging Phenotypes Accompanied by Altered Protein Quality ControlMolecular and Cellular Biology, 2008
- Identification of VCP/p97, Carboxyl Terminus of Hsp70-interacting Protein (CHIP), and Amphiphysin II Interaction Partners Using Membrane-based Human Proteome ArraysMolecular & Cellular Proteomics, 2006